Evidence map›Paper›PMID 31110197›Full record

ArticleScientific reports2019

Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes.

Gajanan P Shelkar, Ratnamala Pavuluri, Pauravi J Gandhi, Aparna Ravikrishnan, Dinesh Y Gawande, Jinxu Liu, Dustin J Stairs, Rajesh R Ugale, Shashank M Dravid

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Review
  3. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Discovery of GluN2A subtype-selectiveActa pharmaceutica Sinica. B · 2024
    Review
  6. Article
  7. Biological chemistry · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.Frontiers in molecular neuroscience · 2021
    Review
  16. Article
  17. Discovery of Dihydropyrrolo[1,2-Journal of medicinal chemistry · 2020
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Gajanan P ShelkarDepartment of Pharmacology, Creighton University, Omaha, NE, 68178, USA.ORCID http://orcid.org/0000-0001-9351-8375
Ratnamala PavuluriDepartment of Pharmacology, Creighton University, Omaha, NE, 68178, USA.
Pauravi J GandhiDepartment of Pharmacology, Creighton University, Omaha, NE, 68178, USA.
Aparna RavikrishnanDepartment of Pharmacology, Creighton University, Omaha, NE, 68178, USA.
Dinesh Y GawandeDepartment of Pharmacology, Creighton University, Omaha, NE, 68178, USA.
Jinxu LiuDepartment of Pharmacology, Creighton University, Omaha, NE, 68178, USA.
Dustin J StairsPsychology, Creighton University, Omaha, NE, 68178, USA.
Rajesh R UgaleDepartment of Pharmaceutical Sciences, R.T.M. Nagpur University, Nagpur, Maharashtra, 440033, India.
Shashank M DravidDepartment of Pharmacology, Creighton University, Omaha, NE, 68178, USA. ShashankDravid@creighton.edu.
Creighton University · USRashtrasant Tukadoji Maharaj Nagpur University · IN

Funding

Function of glutamate delta-1 receptorR01MH116003 · NIMH · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR · 2018 to 2022
$1.9M
Replacing an Animal Resource Facility Cage Washer.G20RR024001 · NCRR · CREIGHTON UNIVERSITY · PI DRESCHER, KRISTEN · 2007 to 2007
$638k
NMDA receptor subtypes in basal gangliaR21NS104705 · NINDS · CREIGHTON UNIVERSITY · PI DRAVID, SHASHANK MANOHAR · 2018 to 2019
$412k
NCRR NIH HHS G20 RR024001NIMH NIH HHS R01 MH116003NINDS NIH HHS R21 NS104705Wellcome Trust
6 · The paper itself

Abstract

The GluN2C- and GluN2D-containing NMDA receptors are distinct from GluN2A- and GluN2B-containing receptors in many aspects including lower sensitivity to Mg

Indexed as

Gene DeletionAnimalsAnxietyDepressionDisease Models, AnimalMaleMice, Inbred C57BLMice, KnockoutReceptors, N-Methyl-D-AspartateSchizophreniaGrin2d protein, mouseNR2C NMDA receptorReceptors, N-Methyl-D-Aspartate

Identifiers

PMID31110197
PMCPMC6527682
OpenAlexW2945412053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.